AAM applauds new Medicaid generic medications proposal

The Association for Accessible Medicines supports legislation to fix a Medicaid penalty against affordable generic medications.
The Association for Accessible Medicines supports legislation to fix a Medicaid penalty against affordable generic medications. | stock photo

Several U.S. House Representatives fought to protect access for patients to affordable medicines and the Association for Accessible Medicines (AAM) applauds their effort, according to a news release.

Reps. G.K. Butterfield (D-NC), Billy Long (R-MO) and Tony Cardenas (D-CA) introduced legislation that fixes a Medicaid penalty against affordable generic medications, the news release states.

Dan Leonard, the president and CEO of AAM said in the release that the Medicaid Generics Penalty increases the risk of shortages as it is currently imposed and threatens the generics market in the long term. 

"The Protecting Access to Affordable Medicines Act is a common-sense solution to address the unintended consequences of the penalty," Leonard said in the news release. "On behalf of America’s patients who rely on generic medicines to contain costs, from the millions who treat chronic health conditions to those being prescribed generics as a proven therapy for COVID-related challenges, we urge House members to cosponsor this bill to protect low-cost generic medicines."